arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

United Parks & Resorts Inc.

PRKS Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus
$40.45
▲ +0.0% Today
as of Sep 4, 16:53 ET
Last 30 days -10.23% Jul 27 → Sep 04
$38.06 $40.45 $42.85 $45.25 $47.64 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$39.97
High
$40.65
Low
$39.74
Volume
$588,354
Avg Vol
$1M
Mkt Cap
$2.0B
P/E (TTM)
18.80
Beta
—
52w High
$56.95
52w Low
$28.77
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 23 items

Aug 19 · 14:17 Zacks
Implied Volatility Surging for United Parks & Resorts Stock Options
Aug 13 · 07:33 StockStory
5 Must-Read Analyst Questions From United Parks & Resorts’s Q2 Earnings Call
Aug 11 · 17:16 Motley Fool
United Parks & Resorts (PRKS) Q2 2026 Earnings Call Transcript
▸ Show all 23 press releases & news Free account →

Overview

52-week range
$29
$57
41% of range
Avg surprise (last 3)
-45.1%
Avg reaction (last 2)
-1.1%
50% positive
Latest IV / EM
52%
EM ±8.2% · $40 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.69$0.00$0.70$1.39$2.08 Actual $-0.26Actual $1.35Actual $1.92Actual $-0.17Actual $1.46Actual $2.08Actual $-0.29Est $-0.23Actual $1.45Est $1.76Actual $1.61Actual $-0.69Est $-0.36Actual $1.34 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-34M$118M$270M$421M$573M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.34 — — — — financials
Mon May 11, 2026Mar/2026 $-0.69 $-0.36 -91.7% -137.9% -6.9% earnings
Tue Sep 30, 2025Sep 2025 $1.61 — — — — financials
Thu Aug 7, 2025Jun/2025 $1.45 $1.76 -17.6% — — earnings
Mon May 12, 2025Mar/2025 $-0.29 $-0.23 -26.1% — +4.6% earnings
Mon Sep 30, 2024Sep 2024 $2.08 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.46 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.17 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.92 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.35 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.26 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$483M$278M—$512M$490M$287M—$546M
Cost of revenue————————
Gross profit————————
Operating income$117M$-8M—$152M$140M$17M—$201M
Net income$63M$-34M—$89M$80M$-16M—$120M
EPS (diluted)$1.34$-0.69—$1.61$1.45$-0.29—$2.08

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$19M$29M$100M$183M$194M$76M$116M$77M
Inventory$59M$57M$52M$52M$53M$51M$46M$51M
Total current assets$244M$241M$283M$407M$399M$256M$270M$256M
Total assets$2.64B$2.61B$2.62B$2.74B$2.73B$2.57B$2.57B$2.58B
Long-term debt$2.26B$2.24B$2.22B$2.22B$2.22B$2.23B$2.23B$2.23B
Total liabilities$3.26B$3.16B$3.05B$3.05B$3.13B$3.05B$3.04B$3.04B
Total equity$-617M$-557M$-436M$-309M$-395M$-478M$-462M$-456M

Implied volatility — last 90 days

39%96%153%210%267% Jun 07 — IV 62% · EM ±8.6%Jun 08 — IV 69% · EM ±9.1%Jun 09 — IV 61% · EM ±7.6%Jun 10 — IV 61% · EM ±7.2%Jun 11 — IV 63% · EM ±6.9%Jun 12 — IV 60% · EM ±6.1%Jun 15 — IV 97% · EM ±7.0%Jun 16 — IV 125% · EM ±7.4%Jun 17 — IV 183% · EM ±7.6%Jun 19 — IV 56% · EM ±12.4%Jun 22 — IV 50% · EM ±10.5%Jun 23 — IV 51% · EM ±10.5%Jun 24 — IV 53% · EM ±10.7%Jun 25 — IV 50% · EM ±9.9%Jun 26 — IV 47% · EM ±9.1%Jun 29 — IV 51% · EM ±9.1%Jun 30 — IV 53% · EM ±9.1%Jul 01 — IV 53% · EM ±8.9%Jul 02 — IV 42% · EM ±6.9%Jul 03 — IV 44% · EM ±6.9%Jul 06 — IV 93% · EM ±12.8%Jul 07 — IV 110% · EM ±14.6%Jul 08 — IV 48% · EM ±6.0%Jul 09 — IV 56% · EM ±6.6%Jul 10 — IV 96% · EM ±10.6%Jul 13 — IV 118% · EM ±9.8%Jul 14 — IV 144% · EM ±10.5%Jul 15 — IV 200% · EM ±11.8%Jul 16 — IV 267% · EM ±11.2%Jul 20 — IV 65% · EM ±15.4%Jul 21 — IV 60% · EM ±14.1%Jul 22 — IV 62% · EM ±14.1%Jul 23 — IV 64% · EM ±14.4%Jul 24 — IV 68% · EM ±15.1%Jul 27 — IV 67% · EM ±14.0%Jul 28 — IV 72% · EM ±14.7%Jul 29 — IV 69% · EM ±13.8%Jul 30 — IV 67% · EM ±13.1%Jul 31 — IV 71% · EM ±13.7%Aug 03 — IV 76% · EM ±13.5%Aug 04 — IV 52% · EM ±8.9%Aug 05 — IV 58% · EM ±9.6%Aug 06 — IV 64% · EM ±10.3%Aug 07 — IV 62% · EM ±9.7%Aug 10 — IV 64% · EM ±8.8%Aug 11 — IV 54% · EM ±7.1%Aug 12 — IV 69% · EM ±8.7%Aug 13 — IV 55% · EM ±6.4%Aug 14 — IV 63% · EM ±7.0%Aug 17 — IV 48% · EM ±4.0%Aug 18 — IV 71% · EM ±5.1%Aug 19 — IV 75% · EM ±4.4%Aug 20 — IV 103% · EM ±4.3%Aug 24 — IV 47% · EM ±9.8%Aug 25 — IV 40% · EM ±8.1%Aug 26 — IV 51% · EM ±10.3%Aug 27 — IV 99% · EM ±19.3%Aug 28 — IV 88% · EM ±16.8%Aug 31 — IV 40% · EM ±7.0%Sep 01 — IV 50% · EM ±8.7%Sep 02 — IV 59% · EM ±9.9%Sep 03 — IV 54% · EM ±8.7%Sep 04 — IV 52% · EM ±8.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in